# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human ...
Gainers
https://ppubs.uspto.gov/pubwebapp/
Morgan Stanley analyst Tejas Savant maintains IsoPlexis (NASDAQ:ISO) with a Equal-Weight and lowers the price target from $5...
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesd...